Abstracts tagged "Rheumatoid arthritis (RA)"

Abstract Number: 2270 • 2015 ACR/ARHP Annual Meeting
Cardiovascular Disease: The Hidden Risk in Persons with Rheumatoid Arthritis
Karen Soikkeli¹ and Glenn Ehresmann², ¹Graduate Nursing (Family Nurse Practitioner Program), Azusa Pacific University, Diamond Bar, CA, ²Rheumatology, Keck School of Medicine, University of Southern California-Los Angeles County Medical Center, Los Angeles, CA
Background/Purpose: Despite the fact that patients with rheumatoid arthritis (RA) experience a 50-60% increased risk of developing cardiovascular disease (CVD), substantial gaps remain in the…
Abstract Number: 2770 • 2015 ACR/ARHP Annual Meeting
Efficacy of Sarilumab Plus Methotrexate in Achieving Clinical Remission, Using 4 Different Definitions, in Patients with Active, Moderate-to-Severe Rheumatoid Arthritis in a Phase 3 Study
Mark C. Genovese¹, Marina Stanislav², Hubert van Hoogstraten³, Renata Martincova⁴, Chunpeng Fan⁵ and Janet van Adelsberg⁶, ¹Division of Rheumatology, Stanford University Medical Center, Palo Alto, CA, ²Research Institute of Rhumato, Moscow, Russia, ³Sanofi, Bridgewater, NJ, ⁴Sanofi Czech Republic, Prague, Czech Republic, ⁵Biostatistics, Sanofi, Bridgewater, NJ, ⁶Clinical Science, Regeneron Pharmaceutials, Inc., Tarrytown, NY
Background/Purpose: Remission is an important clinical outcome in RA1 and is associated with improved physical function and health-related quality of life.2 Several definitions of remission…
Abstract Number: 176 • 2015 ACR/ARHP Annual Meeting
Considerable Discrepancy Between Patient’s Assessment and Ultrasonography Assessment on the Most Affected Joint in Rheumatoid Arthritis
Ryusuke Yoshimi¹, Yukihiro Toyota¹, Naomi Tsuchida¹, Yumiko Sugiyama¹, Yosuke Kunishita¹, Daiga Kishimoto¹, Reikou Kamiyama¹, Kaoru Minegishi¹, Maasa Hama¹, Yohei Kirino¹, Mitsuhiro Takeno^1,2, Atsuhisa Ueda¹ and Yoshiaki Ishigatsubo^1,3, ¹Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan, ²Department of Allergy and Rheumatology, Nippon Medical School, Tokyo, Japan, ³Center for Rheumatic Diseases, Yokosuka City Hospital, Yokosuka, Japan
Background/Purpose: Musculoskeletal ultrasonography (US) is a useful tool for the diagnosis and monitoring of rheumatoid arthritis (RA). It is also helpful for promoting patient-clinician communication…
Abstract Number: 1487 • 2015 ACR/ARHP Annual Meeting
Tocilizumab in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis in Patients Who Have Failed to Disease-Modifying Antirheumatic Drugs: Long Term Results of the Brazilian Cohort
Wiliam Chahade¹, Cristiano Zerbini², Sebastiao Radominski³, Morton Scheinberg⁴, Walber P. Vieira⁵ and Ana Paula Garcia Lucco⁶, ¹Director-Rheumatology, Hospital Servidor Estadual, Sao Paulo, Brazil, ²Centro Paulista de Investigação Clinica, São Paulo, Brazil, ³Universidade Federal do Paraná, Curitiba, Brazil, ⁴Clinical Research, Hospital Abreu Sodre-AACD, Sao Paulo, Brazil, ⁵Hospital Geral de Fortaleza, Fortaleza, Brazil, ⁶Produtos Roche Químicos e Farmacêuticos SA, São Paulo, Brazil
Background/Purpose: Tocilizumab is a humanized monoclonal antibody that binds to IL-6 receptor, blocking its effects. The efficacy and safety of tocilizumab in rheumatoid arthritis (RA)…
Abstract Number: 2334 • 2015 ACR/ARHP Annual Meeting
Proof of Concept Study of the Arthritis Health Journal: An Online Tool to Promote Self-Monitoring in People with Rheumatoid Arthritis (RA)
Diane Lacaille^1,2, Erin Carruthers³, Brendan van As³, Charles H. Goldsmith^3,4, Hilary Horlock⁵, Linda Li^3,6, Anne F. Townsend^3,7, Beverly Mitchell⁸ and Paul Adam⁹, ¹Rheumatology, University of British Columbia, Vancouver, BC, Canada, ²Rheumatology, Arthritis Research Canada, Richmond, BC, Canada, ³Arthritis Research Canada, Richmond, BC, Canada, ⁴Health Sciences, Simon Fraser University, Burnaby, BC, Canada, ⁵Information Management / Information Technology Services, Provincial Health Services Authority, Vancouver, BC, Canada, ⁶Physical Therapy, University of British Columbia, Vancouver, BC, Canada, ⁷Occupational Science and Occupational Therapy, University of British Columbia, Vancouver, BC, Canada, ⁸Business Solutions and Collaboration, Provincial Health Services Authority, Vancouver, BC, Canada, ⁹Rheumatology Liaison, Mary Pack Arthritis Centre, Vancouver, BC, Canada
Background/Purpose: Patient passports have been used in chronic diseases to promote active involvement of patients in their care. In RA, patient monitoring of their disease…
Abstract Number: 3109 • 2015 ACR/ARHP Annual Meeting
Single Cell Gene Expression in Classical Monocytes Correlates with Treatment Response Groups to TNF-Alpha Inhibition in Rheumatoid Arthritis
Theresa Wampler Muskardin¹, Wei Fan², Jessica M. Dorschner³, Zhongbo Jin³, Mark A. Jensen⁴ and Timothy B. Niewold³, ¹Division of Rheumatology, Mayo Clinic, Rochester, MN, ²Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, China, Shanghai, China, ³Division of Rheumatology and Department of Immunology, Mayo Clinic, Rochester, MN, ⁴Department of Immunology and Division of Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: In management of rheumatoid arthritis (RA), initiating effective treatment as soon as possible within the so-called therapeutic “window of opportunity” is the strategy,…
Abstract Number: 2431 • 2014 ACR/ARHP Annual Meeting
Tai Chi and Yoga Are Effective for Improving Physical Function in Adults with Rheumatoid Arthritis- a Meta-Analysis
Heather Greysen and Kathy Lee, School of Nursing, University of California San Francisco, San Francisco, CA
Authors: Greysen, H.1., Lee, K.11. School of Nursing, University of California San FranciscoTitle: Tai Chi and Yoga Are Effective for Improving Physical Function in Adults…
Abstract Number: 1511 • 2014 ACR/ARHP Annual Meeting
COVA322: A Clinical Stage Bispecific TNF/IL-17A Inhibitor for the Treatment of Inflammatory Diseases
Wibke Lembke, Bernd Schlereth, Julian Bertschinger, Dragan Grabulovski and Mathias Locher, Covagen AG, Schlieren, Switzerland
Background/Purpose: Biologic therapeutics such as TNF inhibitors have revolutionized the treatment of inflammatory diseases, including rheumatoid arthritis (RA), psoriasis and psoriatic arthritis. However, there is still…
Abstract Number: 592 • 2014 ACR/ARHP Annual Meeting
Clinical and Psychological Correlates of Sleep Difficulties in Patients with Spondyloarthropathies Compared to Patients with Rheumatoid Arthritis
Konstantinos Kotsis¹, Thomas Hyphantis², Paraskevi V. Voulgari³, Andre F. Carvalho⁴ and Alexandros A. Drosos⁵, ¹Department of Psychiatry, Medical School, University of Ioannina, 45110, Ioannina, Greece., Department of Psychiatry, Medical School, University of Ioannina, 45110, Ioannina, Greece., Ioannina, Greece, ²Department of Psychiatry, Medical School, University of Ioannina, Ioannina 45110, Greece., Department of Psychiatry, Medical School, University of Ioannina, Ioannina 45110, Greece., Ioannina, Greece, ³Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, 45110, Associate Professor of Rheumatology, Ioannina, Greece, ⁴Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil., Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil., Fortaleza, Brazil, ⁵Rheumatology Clinic, Department of Internal Medicine, University of Ioannina, Ioannina, Greece
Background/Purpose Sleep difficulties are common in patients with rheumatological disorders. Patients with Rheumatoid Arthritis (RA) report frequently poor quality sleep, numerous night awakening and difficulty…
Abstract Number: 133 • 2014 ACR/ARHP Annual Meeting
On-Demand Ultrasonography Assessment in the Most Affected Joint Is Efficient for Management of RA Patients in Daily Practice
Ryusuke Yoshimi¹, Takeno Mitsuhiro², Yukihiro Toyota¹, Naomi Tsuchida¹, Yumiko Sugiyama¹, Yosuke Kunishita¹, Daiga Kishimoto¹, Reikou Kamiyama¹, Kaoru Minegishi-Takase¹, Maasa Hama³, Yohei Kirino¹, Atsuhisa Ueda¹ and Yoshiaki Ishigatsubo¹, ¹Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan, ²Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan, ³Yokohama City University Graduate School of Medicine, Yokohama, Japan
Background/Purpose: Musculoskeletal ultrasonography (US) is recognized as a useful tool for the diagnosis and monitoring of rheumatoid arthritis (RA). Although several sets of power Doppler…
Abstract Number: 2377 • 2014 ACR/ARHP Annual Meeting
A Pilot Randomized Controlled Trial of a Tailored Smoking Cessation Intervention for Rheumatoid Arthritis Patients
Pip Aimer¹, Gareth Treharne², Simon Stebbings³, Christopher Frampton⁴, Vicky Cameron¹, Sandra Kirby⁵ and Lisa K. Stamp⁴, ¹Medicine, University of Otago, Christchurch, Christchurch, New Zealand, ²Psychology, University of Otago, Dunedin, New Zealand, ³Dunedin School of Medicine, University of Otago, Dunedin, New Zealand, ⁴Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand, ⁵Arthritis New Zealand, Wellington, New Zealand
Background/Purpose Smoking adversely influences comorbidities in rheumatoid arthritis (RA) and may affect progression of RA. The combination of negative health effects makes a compelling case…
Abstract Number: 1483 • 2014 ACR/ARHP Annual Meeting
Efficacy and Safety of Baricitinib in Japanese Rheumatoid Arthritis Patients during a 52 Week Extension Phase
Yoshiya Tanaka¹, Kahaku Emoto², Zhihong Cai², Douglas E. Schlichting³, Terence Rooney³ and William Macias³, ¹University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, ²Eli Lilly Japan K.K., Kobe, Japan, ³Eli Lilly and Company, Indianapolis, IN
Background/Purpose Baricitinib (bari), an oral JAK1/JAK2 signaling inhibitor, was evaluated in a blinded phase 2b study for 12 weeks as a treatment for rheumatoid arthritis…
Abstract Number: 504 • 2014 ACR/ARHP Annual Meeting
Abatacept after Rituximab in Rheumatoid Arthritis. a Pan-European Collaboration of RA Registries
Axel Finckh¹, David Neto², M. Victoria Hernández³, Florenzo Iannone⁴, Elisabeth Lie⁵, Helena Canhao⁶, K Pavelka⁷, Carl Turesson⁸, Xavier Mariette⁹, Merete Lund Hetland¹⁰ and Jacques Gottenberg¹¹, ¹Rheumatology, Geneva University Hospital, Geneva, Switzerland, ²University of Geneva, Geneva, Switzerland, ³Arthritis Unit. Rheumatology Department, Hospital Clínic of Barcelona, Barcelona, Spain, ⁴Reumatologia Universita e Policlinico di Bari, Bari, Italy, ⁵Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, ⁶Rheumatology Research Unit, Instituto de Medicina Molecular, Universidade de Lisboa, Lisbon, Portugal, ⁷Institute of Rheumatology, Prague, Czech Republic, ⁸Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, ⁹rheumatology, Université Paris-Sud, Le Kremlin Bicêtre, France, ¹⁰DANBIO, Center for Rheumatology and Spine Diseases, Glostrup Univ Hospital, Glostrup, Denmark, ¹¹Rheumatology, Strasbourg University Hospital, Strasbourg, France
Background/Purpose Some observations have suggested that the effectiveness of abatacept (ABA) may be decreased in rheumatoid arthritis (RA) patients (pts) who previously failed rituximab (RTX).(1)…
Abstract Number: 131 • 2014 ACR/ARHP Annual Meeting
Detection of Synovitis and Erosions with an Automated Ultrasound System: Data from a Prospective Cohort with Early and Established RA
Matthias Witt¹, Janette Frielinghausen², Jan Leipe², Hendrik Schulze-Koops², Ruediger Mueller³ and Mathias Grunke², ¹Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany, ²Division for Rheumatology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany, ³Rheumatology, Kantonspital St. Gallen, St. Gallen, Switzerland
Background/Purpose: Arthrosonography has proven to be a sensitive and reliable, but time-consuming method for the evaluation of arthritis in small joints of patients with RA…
Abstract Number: 2385 • 2014 ACR/ARHP Annual Meeting
Reasons for Non-Vaccination in Rheumatoid Arthritis and Spondyloarthritis Patients
Charlotte Hua¹, Jacques Morel², Bernard Combe¹ and Cédric Lukas^1,3, ¹Immuno-Rhumatologie, Hôpital Lapeyronie, Montpellier, France, ²Department of Rheumatology, Hôpital Lapeyronie, Montpellier, France, ³Immuno-Rhumatologie, Hopital Lapeyronie, Montpellier, France
Background/Purpose: Patients with inflammatory rheumatic diseases are at increased risk of infections when compared to healthy controls. Despite the fact that part of these infections…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].